Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Morphine for Refractory Dyspnea in Advanced COPD
NCT02429050Phase 4Completed
- Sponsor
- Maastricht University Medical Center+
- Start
- Nov 2016
- Primary completion
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of morphine in chronic obstructive pulmonary disease (COPD), sponsored by Maastricht University Medical Center+. Started Nov 2016; status: completed.
02
Drugs
morphine
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02429050.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02429050.